Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test may predict hidden surgical risks

NCT ID NCT06639906

Knowledge-focused Sponsor: Manisa Celal Bayar University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 16, 2026 · Updated 3 times

Summary

This study looked at whether certain substances in the blood (decorin and TGF β1) can predict the presence and severity of internal scar tissue (adhesions) before abdominal surgery. Researchers studied 56 women with a history of prior abdominal surgery who were scheduled for a gynecological operation. By comparing blood test results with actual findings during surgery, they hope to develop a non-invasive way to assess adhesion risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test that helps surgeons know ahead of time if a patient has internal scar tissue, making surgery safer.
What could go wrong
This is a small, completed study with only 56 participants. The results may not apply to everyone, and the blood markers may not be reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

56 people

The number who actually took part.

Started

Jan 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with Intraabdominal Adhesions

Ages

18 to 50 years

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who are hospitalized for gynecological reasons with a planned laparotomy or laparoscopic abdominal surgery * Patients with at least 1 previous cesarean section or history of previous abdominal surgery (laparoscopy or laparotomy) Exclusion Criteria: * Patients who do not agree to participate in the study will not be included in the study. * Pregnant patients will not be included in the study (so that the physiological changes of pregnancy do not affect the results) * Presence of preoperative clinical or laboratory findings of infection (such as high fever, tachycardia, leukocytosis, high CRP) * Presence of hematological or coagulation disorders * History or presence of cancer treatment * History or presence of connective tissue disease * Presence of diabetes * Being under 18 years of age will be considered as exclusion criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesions abdominal are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adhesions abdominal Surgery

Contacts and locations

Locations

  • Manisa Celal Bayar University

    Manisa, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.